| Name |
|---|
EBM Geneepidermolysis bullosa, macular type |
MCDR3 Genemacular dystrophy, retinal 3 |
MCDR1 Genemacular dystrophy, retinal, 1 (North Carolina type) |
MCDR4 Genemacular dystrophy, retinal, 4 (North Carolina type with progressive sensorineural hearing loss) |
CYMD Genecystoid macular dystrophy |
VMD1 Genevitelliform macular dystrophy, atypical |
MDBS2 Genebutterfly-shaped pigmentary macular dystrophy 2 |
CMM Genecutaneous malignant melanoma/dysplastic nevus Malignant melanoma is a malignant neoplasm of melanocytes, arising de novo or from a pre-existing benign nevus, which occurs most often in the skin but also may involve other sites.[supplied by OMIM, Jul 2002] |
CTAGE1 Genecutaneous T-cell lymphoma-associated antigen 1 Predicted to be involved in endoplasmic reticulum to Golgi vesicle-mediated transport; protein secretion; and vesicle cargo loading. Predicted to be located in membrane. Predicted to be active in endoplasmic reticulum exit site and endoplasmic reticulum membrane. [provided by Alliance of Genome Resources, Mar 2025] |
CMM4 GeneMelanoma, cutaneous malignant, 4 |
CMM7 GeneMelanoma, cutaneous malignant, susceptibility to, 7 |
LOC100421663 Genecutaneous T-cell lymphoma-associated antigen 1 pseudogene |
LOC100421630 Genecutaneous T-cell lymphoma-associated antigen 1 pseudogene |
LOC100288590 Genecutaneous T-cell lymphoma-associated antigen 1 pseudogene |
PICSAR GeneP38 inhibited cutaneous squamous cell carcinoma associated lincRNA |